Martin Evans

Martin Evans

Fundador en
Celixir Plc
.

Fortuna: 2 M $ al 31/12/2025

85 años
Health Technology
Consumer Services

Perfil

Martin John Evans is the founder of Oncogeni Ltd. founded in 2019, holding the title of Director since 2022.
Dr. Evans was the founder of Cell Therapy Ltd. founded in 2009, holding the titles of President & Chief Scientific Officer from 2015 to 2018.
Dr. Evans is the founder of Cardiogeni Plc founded in 2016, holding the titles of Director & Chief Scientific Officer since 2016.
Former jobs include Non-Executive Director at Coiled Therapeutics Plc from 2024 to 2025 and President at the University of Cardiff.
Education history includes a doctorate from University College London conferred in 1969 and an undergraduate degree from Christ's College (United Kingdom) conferred in 1963.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18,92 %
21/04/2026 16.855.254 ( 18,92 % ) 2 M $ 31/12/2025
03/12/2024 269 ( 0 % ) 35 $ 31/07/2026

Cargos activos de Martin Evans

EmpresasCargoInicio
Fundador 28/12/2016
Fundador 01/05/2019

Antiguos cargos conocidos de Martin Evans.

EmpresasCargoFin
ROQT THER Director Técnico/Científico/I+D 23/05/2024
Presidente -
Fundador -
Ver el detalle de la experiencia de Martin Evans.

Formación de Martin Evans.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

27

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology